IMF Videos Search Content For Care Partner (351) Patient (347) Healthcare Provider (213) Healthcare Professional (210) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (22) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (21) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (185) Financial Considerations (15) Frontline Therapy (83) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (69) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (56) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (42) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (136) Research Updates (193) Symptom Management (114) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (147) High-Risk Myeloma (96) High-risk Smoldering Myeloma (70) Late Relapse (4–6 Lines of Therapy) (158) MGUS (85) Newly Diagnosed (Pre-Treatment or First Treatment) (158) Smoldering Myeloma (109) Types of Therapy Immunomodulatory drugs (IMiDs) (94) Immunotherapies (CAR T; BiTE, etc.) (161) Monoclonal antibodies (78) Proteasome inhibitors (66) Stem cell transplant (84) Steroids (63) Supportive Care (152) Year Published 2026 (44) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (103) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (29) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Kilimanjaro Study: Etentamig Plus Pomalidomide-Dexamethasone Shows Robust Efficacy in Relapsed Myeloma January 21, 2026 ASH CARTITUDE-4: Exceptional Long-Term Outcomes with Cilta-cel in Standard-Risk Relapsed Myeloma January 20, 2026 ASH Anitocabtagene Autoleucel iMMagine-1 Trial: Exceptional Safety and Durability in Relapsed Myeloma January 16, 2026 ASH Understanding ELREXFIO & Bispecific Antibodies for Multiple Myeloma January 16, 2026 Emerging Therapies MajesTEC-3: Teclistamab-Daratumumab Establishes New Standard of Care in Early Relapsed Myeloma January 12, 2026 ASH KLN-1010 In Vivo CAR-T Therapy: Revolutionary Off-the-Shelf Treatment for Multiple Myeloma January 9, 2026 ASH CAR T & Bispecific Antibodies: The Biggest Myeloma Advances from ASH 2025 January 8, 2026 Recent News and Developments Top Myeloma Research Presented at ASH 2025: Easy-to-Understand Insights for Patients and Care Partners January 7, 2026 ASH Cilta-cel Safety Enhancement: Modifiable Risk Factors for Delayed Neurotoxicity and Non-Relapse Mortality December 19, 2025 ASH Myeloma in a Minute or Less: How to Manage Pain with Multiple Myeloma December 18, 2025 Myeloma in a Minute IMWG Conference Series: Making Sense of Treatment December 17, 2025 IMWG Multiple Myeloma Breakthroughs and Patient Voices from ASH in Orlando December 8, 2025 Facebook Live Load More
